Almirall, S.A./€ALM
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Almirall, S.A.
Almirall, S.A. is a pharmaceutical company headquartered in Barcelona, Spain. It specializes in the development and commercialization of proprietary medicines, with a focus on dermatology and other specialist-driven therapeutic areas. Almirall's notable products target conditions such as psoriasis, atopic dermatitis, and actinic keratosis. Founded in 1943, the company has expanded its geographical footprint across Europe and North America through strategic acquisitions and partnerships. Almirall emphasizes research and development, maintaining a pipeline of innovative treatments aimed at unmet medical needs. Its strategic positioning is reinforced by collaborations with healthcare professionals and institutions to enhance patient care.
Ticker
€ALM
Sector
Primary listing
BME
Industry
Pharmaceuticals
Headquarters
Employees
2,026
ISIN
ES0157097017
Website
Almirall, S.A. Metrics
BasicAdvanced
€2.3B
93.03
€0.11
0.30
€0.15
1.40%
Price and volume
Market cap
€2.3B
Beta
0.3
52-week high
€11.30
52-week low
€9.81
Dividend rate
€0.15
Financial strength
Current ratio
2.284
Quick ratio
1.616
Long term debt to equity
22.762
Total debt to equity
22.762
Dividend payout ratio (TTM)
13.50%
Interest coverage (TTM)
4.20%
Profitability
EBITDA (TTM)
191.638
Gross margin (TTM)
76.22%
Net profit margin (TTM)
2.37%
Operating margin (TTM)
6.44%
Effective tax rate (TTM)
48.42%
Revenue per employee (TTM)
€510,000
Management effectiveness
Return on assets (TTM)
1.76%
Return on equity (TTM)
1.64%
Valuation
Price to earnings (TTM)
93.026
Price to revenue (TTM)
2.203
Price to book
1.51
Price to tangible book (TTM)
9.82
Price to free cash flow (TTM)
488.557
Free cash flow yield (TTM)
0.20%
Free cash flow per share (TTM)
2.17%
Dividend yield (TTM)
1.40%
Growth
Revenue change (TTM)
12.33%
3-year revenue growth (CAGR)
6.83%
10-year revenue growth (CAGR)
2.02%
3-year earnings per share growth (CAGR)
-25.75%
10-year earnings per share growth (CAGR)
-27.38%
Bulls say / Bears say
Almirall's stock has surged over 30% since January 2025, increasing its market capitalization by €642 million to €2.645 billion, reflecting strong investor confidence. (cincodias.elpais.com)
The company reported a 15% increase in total sales in Q1 2025, reaching €284 million, with a 35% rise in EBITDA to €70.9 million, indicating robust financial health. (cincodias.elpais.com)
Almirall's strategic licensing agreement with Novo Nordisk for the monoclonal antibody NN-8828 positions it to develop treatments for inflammatory and dermatological diseases, potentially expanding its product portfolio. (marketscreener.com)
Despite revenue growth, Almirall's net income for Q1 2025 was €24.35 million, resulting in a high P/E ratio of 98.20, which may indicate overvaluation. (stockanalysis.com)
The company's net profit margin in Q1 2025 was 1.14%, suggesting that increased revenues are not translating into proportional profitability. (google.com)
Almirall's stock price has experienced volatility, with a 52-week range between €8.03 and €11.30, which may concern risk-averse investors. (stockanalysis.com)
Data summarised monthly by Lightyear AI. Last updated on 27 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Almirall, S.A. stock?
Almirall, S.A. (ALM) has a market cap of €2.3B as of July 04, 2025.
What is the P/E ratio for Almirall, S.A. stock?
The price to earnings (P/E) ratio for Almirall, S.A. (ALM) stock is 93.03 as of July 04, 2025.
Does Almirall, S.A. stock pay dividends?
Yes, the Almirall, S.A. (ALM) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is €0.14904 and the yield is 1.4%. Almirall, S.A. has a payout ratio of 13.5% on a trailing twelve-month basis.
When is the next Almirall, S.A. dividend payment date?
The next Almirall, S.A. (ALM) dividend payment date is unconfirmed.
What is the beta indicator for Almirall, S.A.?
Almirall, S.A. (ALM) has a beta rating of 0.3. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.